Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma

J Clin Endocrinol Metab. 2009 Apr;94(4):1081-3. doi: 10.1210/jc.2009-0344.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / genetics
  • Carrier State
  • Cholesterol, HDL / blood
  • Genetic Variation
  • Humans
  • Lipase / genetics*
  • Lipoproteins, HDL / blood*
  • Liver / enzymology*
  • Mutation
  • Risk Factors

Substances

  • Cholesterol, HDL
  • Lipoproteins, HDL
  • Lipase